Capstone Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
SGA
Capstone Asset Management's NVO Position: Q2 2017 in Review
Capstone Asset Management reduced its Novo Nordisk (NVO) stake by 9% in Q2 2017, selling an estimated $276K and leaving 138,470 shares worth $2.97M. The position accounts for 0.08% of the portfolio, ranked #284.
Capstone Asset Management first reported a position in NVO in Q2 2013 and has held it in 17 quarters since. The position peaked at $4.01M in Q4 2015. 484 funds tracked by Wall St. Rank hold NVO as of Q2 2017.
- Capstone Asset Management held 138,470 shares of Novo Nordisk worth $2.97M as of Q2 2017.
- Capstone Asset Management sold 13,700 Novo Nordisk shares in Q2 2017, an estimated $276K.
- Novo Nordisk made up 0.08% of Capstone Asset Management's portfolio in Q2 2017, its #284 holding.
- Capstone Asset Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 17 quarters since.
- Capstone Asset Management's Novo Nordisk position peaked at $4.01M in Q4 2015.
- 484 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2017.
Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.